IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma. [electronic resource]
Producer: 20050919Description: 1407-14 p. digitalISSN:- 0006-4971
- Animals
- Bone Marrow Cells -- pathology
- Cell Differentiation -- drug effects
- Cell Line, Tumor
- Cells, Cultured
- Hematopoietic Stem Cells
- Humans
- Interleukin-3 -- pharmacology
- Leukocyte Common Antigens
- Mice
- Multiple Myeloma -- drug therapy
- Osteoblasts -- drug effects
- Osteoclasts -- drug effects
- Stromal Cells -- pathology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.